These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 24970022)
1. Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1‑AS expression. Liu T; Huang Y; Chen J; Chi H; Yu Z; Wang J; Chen C Mol Med Rep; 2014 Sep; 10(3):1275-81. PubMed ID: 24970022 [TBL] [Abstract][Full Text] [Related]
2. Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124. Yue D; Guanqun G; Jingxin L; Sen S; Shuang L; Yan S; Minxue Z; Ping Y; Chong L; Zhuobo Z; Yafen W Cell Biol Int; 2020 Feb; 44(2):630-636. PubMed ID: 31743528 [TBL] [Abstract][Full Text] [Related]
3. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Faghihi MA; Modarresi F; Khalil AM; Wood DE; Sahagan BG; Morgan TE; Finch CE; St Laurent G; Kenny PJ; Wahlestedt C Nat Med; 2008 Jul; 14(7):723-30. PubMed ID: 18587408 [TBL] [Abstract][Full Text] [Related]
4. Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence. Kimura A; Hata S; Suzuki T J Biol Chem; 2016 Nov; 291(46):24041-24053. PubMed ID: 27687728 [TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells. Chen LM; Lin ZY; Zhu YG; Lin N; Zhang J; Pan XD; Chen XC Eur J Pharmacol; 2012 Jan; 675(1-3):15-21. PubMed ID: 22166376 [TBL] [Abstract][Full Text] [Related]
6. HuD regulates coding and noncoding RNA to induce APP→Aβ processing. Kang MJ; Abdelmohsen K; Hutchison ER; Mitchell SJ; Grammatikakis I; Guo R; Noh JH; Martindale JL; Yang X; Lee EK; Faghihi MA; Wahlestedt C; Troncoso JC; Pletnikova O; Perrone-Bizzozero N; Resnick SM; de Cabo R; Mattson MP; Gorospe M Cell Rep; 2014 Jun; 7(5):1401-1409. PubMed ID: 24857657 [TBL] [Abstract][Full Text] [Related]
7. BACE1-AS prevents BACE1 mRNA degradation through the sequestration of BACE1-targeting miRNAs. Zeng T; Ni H; Yu Y; Zhang M; Wu M; Wang Q; Wang L; Xu S; Xu Z; Xu C; Xiong J; Jiang J; Luo Y; Wang Y; Liu H J Chem Neuroanat; 2019 Jul; 98():87-96. PubMed ID: 30959172 [TBL] [Abstract][Full Text] [Related]
8. The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression. Li F; Wang Y; Yang H; Xu Y; Zhou X; Zhang X; Xie Z; Bi J BMC Mol Biol; 2019 Oct; 20(1):23. PubMed ID: 31570097 [TBL] [Abstract][Full Text] [Related]
9. Increased BACE1-AS long noncoding RNA and β-amyloid levels in heart failure. Greco S; Zaccagnini G; Fuschi P; Voellenkle C; Carrara M; Sadeghi I; Bearzi C; Maimone B; Castelvecchio S; Stellos K; Gaetano C; Menicanti L; Martelli F Cardiovasc Res; 2017 Apr; 113(5):453-463. PubMed ID: 28158647 [TBL] [Abstract][Full Text] [Related]
10. SEPT8 modulates β-amyloidogenic processing of APP by affecting the sorting and accumulation of BACE1. Kurkinen KM; Marttinen M; Turner L; Natunen T; Mäkinen P; Haapalinna F; Sarajärvi T; Gabbouj S; Kurki M; Paananen J; Koivisto AM; Rauramaa T; Leinonen V; Tanila H; Soininen H; Lucas FR; Haapasalo A; Hiltunen M J Cell Sci; 2016 Jun; 129(11):2224-38. PubMed ID: 27084579 [TBL] [Abstract][Full Text] [Related]
11. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models. Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932 [TBL] [Abstract][Full Text] [Related]
12. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of β-asarone on lncRNA BACE1-mediated induction of autophagy in a model of Alzheimer's disease. Wang Z; Zhou J; Zhang B; Xu Z; Wang H; Sun Q; Wang N Behav Brain Res; 2024 Apr; 463():114896. PubMed ID: 38316166 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease. Liu CG; Wang JL; Li L; Wang PC Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165 [TBL] [Abstract][Full Text] [Related]
15. BACE1 elevation is involved in amyloid plaque development in the triple transgenic model of Alzheimer's disease: differential Aβ antibody labeling of early-onset axon terminal pathology. Cai Y; Zhang XM; Macklin LN; Cai H; Luo XG; Oddo S; Laferla FM; Struble RG; Rose GM; Patrylo PR; Yan XX Neurotox Res; 2012 Feb; 21(2):160-74. PubMed ID: 21725719 [TBL] [Abstract][Full Text] [Related]
16. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease. Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613 [TBL] [Abstract][Full Text] [Related]
17. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model. Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113 [TBL] [Abstract][Full Text] [Related]
18. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis. Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193 [TBL] [Abstract][Full Text] [Related]
19. Control of BACE1 degradation and APP processing by ubiquitin carboxyl-terminal hydrolase L1. Zhang M; Deng Y; Luo Y; Zhang S; Zou H; Cai F; Wada K; Song W J Neurochem; 2012 Mar; 120(6):1129-38. PubMed ID: 22212137 [TBL] [Abstract][Full Text] [Related]
20. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease. Majercak J; Ray WJ; Espeseth A; Simon A; Shi XP; Wolffe C; Getty K; Marine S; Stec E; Ferrer M; Strulovici B; Bartz S; Gates A; Xu M; Huang Q; Ma L; Shughrue P; Burchard J; Colussi D; Pietrak B; Kahana J; Beher D; Rosahl T; Shearman M; Hazuda D; Sachs AB; Koblan KS; Seabrook GR; Stone DJ Proc Natl Acad Sci U S A; 2006 Nov; 103(47):17967-72. PubMed ID: 17098871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]